For the first time, dedicated efforts of viral hepatitis experts have ensured that besides vaccination for HBV, testing and treatment for HBV and HCV is inlcuded in the new edition of the European Code Against Cancer (ECAC5, recommendation 12)!
Please find the details of the ECAC5 here: European Code Against Cancer | 14 ways to prevent cancer.
The European Code Against Cancer, 5th edition (ECAC5) consists of 14 recommendations based on current scientific evidence on personal behavioural factors, environmental factors, and medical interventions, specific to the general population in the EU. For the first time, ECAC5 is aimed not only at individuals but also at policy-makers, including 14 complementary recommendations on population-level measures that may reinforce the recommendations for individuals. These recommendations provide co-benefits to prevent other noncommunicable diseases (NCDs) with similar underlying risk factors, and opportunities for health promotion. Together, the ECAC5 recommendations provide a roadmap to reduce cancer risk, tackle misconceptions about cancer, and improve public health and well-being.
Please also check our webpage on the VHPB technical meeting: Viral hepatitis in Europe’s Beating Cancer Plan – Prevention and control of viral hepatitis as cancer prevention opportunities (27-28 March 2025, Antwerp, Belgium) – VHPB.